Kwan-yung Y. Au

LKS Faculty Of Medicine
Hong Kong, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Secreted lumican from the tumor microenvironment potentiates HCC stemness and progression.

Secreted lumican from the tumor microenvironment potentiates HCC stemness and progression.

Journal: Hepatology communications
Published: December 31, 2024

Sortilin-Driven Cancer Secretome Enhances Tumorigenic Properties of Hepatocellular Carcinoma via de Novo Lipogenesis.

Sortilin-Driven Cancer Secretome Enhances Tumorigenic Properties of Hepatocellular Carcinoma via de Novo Lipogenesis.

Journal: The American journal of pathology
Published: March 08, 2023

Evaluation of a group-based sensorimotor intervention programme to improve Chinese handwriting of primary school students.

Evaluation of a group-based sensorimotor intervention programme to improve Chinese handwriting of primary school students.

Journal: Heliyon
Published: May 03, 2022

Sex-specific analysis of microRNA profiles in HBV-associated cirrhosis by small RNA-sequencing.

Sex-specific analysis of microRNA profiles in HBV-associated cirrhosis by small RNA-sequencing.

Journal: Hepatology communications
Published: April 22, 2022

Stanniocalcin 1 is a serum biomarker and potential therapeutic target for HBV-associated liver fibrosis.

Stanniocalcin 1 is a serum biomarker and potential therapeutic target for HBV-associated liver fibrosis.

Journal: The Journal of pathology
Published: October 12, 2021

A Clinicopathological Study of Young-onset Hepatocellular Carcinoma.

A Clinicopathological Study of Young-onset Hepatocellular Carcinoma.

Journal: Anticancer research
Published: April 22, 2021

An Immunohistochemical Study of β-catenin Expression and Immune Cell Population in Metastatic Carcinoma to the Liver.

An Immunohistochemical Study of β-catenin Expression and Immune Cell Population in Metastatic Carcinoma to the Liver.

Journal: Pathology oncology research : POR
Published: January 15, 2021

Anti-tumour effects of PIM kinase inhibition on progression and chemoresistance of hepatocellular carcinoma.

Anti-tumour effects of PIM kinase inhibition on progression and chemoresistance of hepatocellular carcinoma.

Journal: The Journal of pathology
Published: January 02, 2020
Showing 1-8 of 8

Last Updated: 09/26/2026